Precisis AG
Venture Financing
September 2021
€ 20 million
September 2021
€ 20 million
Transaction Highlights
- Precisis is conducting clinical studies to obtain CE mark for the treatment of brain disorders with its next-gen neurostimulation device
- Precisis mandated FCF to arrange the financing of its clinical studies and commercialization of its medical device to support its growth story
- Through its automated investor approach, FCF has successfully synchronized the approach and coordination of > 400 global blue-chip investors (i.e. with AUM > USD 1bn) and to the largest strategic MedTech acquirers who have conducted detailed due diligence
- Having successfully received term sheets with different transaction structures, FCF advised Precisis on the transaction options that best fit to the Company’s growth plans and managements’ / shareholders’ interests
- Precisis has eventually chosen for a EUR 20m venture financing from Cochlear Ltd., the global leader in implantable hearing solutions
- The collaboration will leverage Precisis’ demonstrated ability to trigger a paradigm shift in brain stimulation and benefit from Chochlear’s expertise in the stimulation field and strong commercial network
FCF’s Role in the Transaction
- Professional preparation of investment documents, strategic positioning of Precisis and fine-tuning of the equity story
- Development of an in-depth, integrated financial model, including sales forecasting based on a bottom-up market model
- Intelligent investor selection based on a proprietary investor database and intelligent search algorithm
- Automated outreach and streamlining of > 400 relevant international venture capital, strategic and family office investors
- Coordination and moderation of over 75 management and follow-up calls
- Efficient process management through support in managing the due diligence process, preparation of several financial documents and providing capacities to the management (FCF as external finance department)
- Term sheet structuring and negotiation including support of the closing process
